- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Ruxolitinib cream
Total 1702 results
-
Children's Hospital Medical Center, CincinnatiRecruitingBronchiolitis Obliterans (BO) | Hematopoietic Stem Cell Transplant (HSCT)United States
-
University of JenaCompleted
-
University of Michigan Rogel Cancer CenterCompletedHemophagocytic Syndrome (HPS)United States
-
Margherita MaffioliUnknown
-
University of PittsburghWithdrawnHead and Neck Squamous Cell Carcinoma
-
Sichuan UniversityNot yet recruitingGVHD | Acute Stem Cell Transplant ComplicationsChina
-
Multinational Center for Quality of Life Research...Not yet recruiting
-
University of RochesterIncyte CorporationCompletedDiscoid Lupus ErythematosusUnited States
-
Tianjin Medical University General HospitalWithdrawnNeuromyelitis Optica Spectrum Disorder RelapseChina
-
Qilu Hospital of Shandong UniversityCompleted
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
Kantonsspital AarauNovartis; University Hospital, Basel, Switzerland; Clinical Trial Unit, University...TerminatedCancer CachexiaSwitzerland
-
Novartis PharmaceuticalsAvailable
-
Novartis PharmaceuticalsAvailablePrimary Myelofibrosis (PMF) | Polycythemia Vera (PV) | Post Polycythemia Myelofibrosis (PPV MF) | Thrombocythemia Myelofibrosis (PET-MF) | Severe/Very Severe COVID-19 Illness | Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD) | Steroid Refractory Chronic Graft Versus Host Disease...
-
Columbia UniversityIncyte CorporationActive, not recruitingAdvanced Cutaneous Squamous Cell CarcinomaUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)
-
Incyte CorporationNo longer available
-
University Health Network, TorontoTerminatedCOVID-19 | PneumoniaCanada
-
Stefanie Sarantopoulos, MD, PhD.National Institutes of Health (NIH); Incyte Corporation; Rigel PharmaceuticalsNot yet recruitingChronic Graft Versus Host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; Incyte CorporationRecruitingMyelofibrosis Due to and Following Polycythemia VeraUnited States
-
Novartis PharmaceuticalsActive, not recruitingGraft vs Host DiseaseJapan, Slovakia, Taiwan, Spain, Korea, Republic of, Thailand, Canada, Russian Federation, Italy, Turkey, India, Czechia, Brazil, Switzerland
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingT-cell Large Granular Lymphocyte Leukemia | T-cell Lymphomas | T-cell Prolymphocytic Leukemia | NK-Cell LymphomasUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Columbia UniversityLocks of Love; Alopecia Areata Initiative - Gates FoundationCompletedAlopecia AreataUnited States
-
Novartis PharmaceuticalsCompletedMyelofibrosisBelgium, Colombia, Canada, Italy, Spain, Austria, Germany, Czechia, Thailand, Hungary, Greece, Argentina, Brazil, Israel, Russian Federation, Mexico, Portugal, South Africa, Tunisia, Slovakia, Saudi Arabia, Poland, Algeria, Ireland, Mor...
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
Novartis PharmaceuticalsNot yet recruitingSteroid-refractory Acute Graft Versus Host Disease
-
Novartis PharmaceuticalsRecruitingGraft-versus-Host DiseaseKorea, Republic of
-
Massachusetts General HospitalIncyte CorporationRecruitingPolycythemia Vera | Essential ThrombocythemiaUnited States
-
Incyte CorporationRecruitingAnemia | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, France, Italy, Japan, United Kingdom, Canada
-
Massachusetts General HospitalWashington University School of Medicine; Medical College of Wisconsin; Vanderbilt... and other collaboratorsRecruitingAcute Myeloid Leukemia | Allogeneic Stem Cell Transplantation | Acute Myeloid Leukemia in RemissionUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationActive, not recruitingLeukemia | Chronic Myelomonocytic LeukemiaUnited States
-
Yi-Lun WangCompletedSteroid Refractory GVHDTaiwan
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... and other collaboratorsCompletedIDH2 Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Chronic-phase MyelofibrosisUnited States, Canada
-
University of California, San FranciscoIncyte CorporationCompleted
-
Incyte CorporationCompleted
-
Philipps University Marburg Medical CenterCompletedCOVID | ARDS, HumanGermany
-
Novartis PharmaceuticalsNovartis is the Marketing Authorization Holder for Jakavi outside the US.No longer availableSevere/Very Severe COVID-19 Illness
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
The Lymphoma Academic Research OrganisationNovartisCompletedHodgkin's LymphomaFrance, Belgium
-
Washington University School of MedicineIncyte CorporationNo longer available
-
Novartis PharmaceuticalsCompletedThalassemia MajorThailand, Turkey, Italy, Lebanon, Greece
-
Sunnybrook Health Sciences CentreNovartisCompleted
-
University of North Carolina, CharlotteTeva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States
-
Incyte CorporationRecruitingMyeloproliferative NeoplasmsSpain, Japan, France, Italy, Germany, Australia, United Kingdom, Denmark, Canada
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Novartis PharmaceuticalsIncyte CorporationCompletedCytokine Storm (Covid-19)United States, Colombia, Turkey, Spain, United Kingdom, Germany, Peru, Russian Federation, Brazil, France, Mexico, Argentina
-
Grupo Cooperativo de Hemopatías MalignasCompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2Mexico
-
Kartos Therapeutics, Inc.UnknownPolycythemia VeraUnited States, Poland, Spain, Germany, Hungary, France